| Identification | Back Directory | [Name]
Cindunistat ,PF-00572986
PHA-84250 | [CAS]
364067-22-1 | [Synonyms]
Cindunistat
Cindunistat ,PF-00572986
PHA-84250
S-[2-[(1-iminoethyl) amino]ethyl]-2-methyl-L-custeine
L-Cysteine, S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-
(R)-3-((2-Acetimidamidoethyl)thio)-2-amino-2-methylpropanoic acid | [Molecular Formula]
C8H17N3O2S | [MOL File]
364067-22-1.mol | [Molecular Weight]
219.3 |
| Hazard Information | Back Directory | [Uses]
Cindunistat (SD-6010) is a potent, orally active and selective iNOS inhibitor[1]. | [References]
[1] Hellio le Graverand MP, et al. A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee. Ann Rheum Dis. 2013;72(2):187-195. DOI:10.1136/annrheumdis-2012-202239 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|